Treatment Outcome of Ortho MTA (BioMTA®) Cement vs AH Plus® Bioceramic Sealer (Dentsply).
Clinical Outcome of Root Canal Treatment With Ortho MTA (BioMTA®) Cement and AH Plus® Bioceramic Sealer (Dentsply). A Randomized Controlled Trial.
1 other identifier
interventional
70
1 country
1
Brief Summary
The use of bioceramics materials as root canal fillings in endodontics is gaining traction due to their excellent biocompatibility, antibacterial and sealing abilities. They are dispensed in the form of sealers and cements to be used with gutta-percha or mixed with liquids to form a paste. Recently, Ortho MTA (BioMTA®) cement is clinically available as a root filling material, without the need for gutta-percha. The purpose of this randomized controlled clinical trial is to compare clinical outcome between the novel Ortho MTA (BioMTA®) and the conventional gutta-percha with bioceramic sealer, when used as obturating materials in root canal treatment. This research aims to compare the healing outcome of infected teeth treated by root canal treatment and root-filled using MTA cement (Ortho MTA, BioMTA® Seoul Korea) or bioceramic sealer (AH Plus® Bioceramic Sealer (Dentsply). The sealer can be used alone or in combination with gutta-percha obturating cones, injected gutta-percha material or core-carriers master cones. In vitro studies have demonstrated the capability of MTA to generate hydroxyapatite precipitates that penetrate into dentinal tubules.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedStudy Start
First participant enrolled
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 28, 2024
September 1, 2023
1.3 years
July 12, 2023
August 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Primary Objectives (Change in baseline periapical lesion size at 6 month and 12 month)
Change in baseline periapical lesion size at 6 month and 12 month
6, 12 months
Secondary Outcomes (1)
Secondary Objectives (Change in baseline post-operative pain at Day 1, Day 3 and Day 7 post treatment)
1, 3, 7 days
Study Arms (2)
GP and AH Plus sealer
ACTIVE COMPARATORRoot canal obturation using gutta percha and AH Plus® bioceramic sealer.
Ortho MTA
EXPERIMENTALRoot canal obturation using Ortho MTA cement.
Interventions
Ortho MTA has a fine granularity for only 2 microns. It penetrates into dental tubules and fuses itself to the surface where it is applied. In addition, it prevents micro-leakage by forming an interfacing layer of hydroxyapatite (Hap) between the OrthoMTA and the canal wall.
AH Plus Sealer is a calcium silicate-based root canal sealer. Tricalcium Silicate interacts with body fluids to release calcium and hydroxide ions that promote hydroxyapatite (HA) formation.
Eligibility Criteria
You may qualify if:
- A preoperative periapical radiograph will be required for diagnosis.
- Subjects at least 21 years old to 95 years old.
- Medically healthy
- In a patient with multiple teeth requiring root canal treatment, only 1 tooth from each side will be included and selected at random.
- Tooth requiring root canal treatment presenting with periapical radiolucency.
You may not qualify if:
- Patients below 21 years old.
- Pregnant women.
- Patients with autoimmune disease and uncontrolled diabetes.
- Teeth with periodontal probing depth 5mm or more.
- Incomplete root formation that is detected radiographically.
- Cracked teeth.
- Teeth are deemed to have poor restorative prognosis.
- Teeth with adjacent teeth on the same side that require root canal treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital, Singapore
Singapore, 119074, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2023
First Posted
August 9, 2023
Study Start
September 21, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
August 28, 2024
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share